Form 8-K - Current report:
SEC Accession No. 0001437749-22-011845
Filing Date
2022-05-11
Accepted
2022-05-11 09:57:45
Documents
16
Period of Report
2022-05-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dyai20220216_8k.htm   iXBRL 8-K 33389
2 EXHIBIT 10.1 ex_336879.htm EX-10.1 119171
3 EXHIBIT 99.1 ex_336880.htm EX-99.1 12334
8 ex_316856img001.jpg GRAPHIC 2561
  Complete submission text file 0001437749-22-011845.txt   325582

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dyai-20220510.xsd EX-101.SCH 3601
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dyai-20220510_def.xml EX-101.DEF 11532
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyai-20220510_lab.xml EX-101.LAB 15414
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyai-20220510_pre.xml EX-101.PRE 11688
10 EXTRACTED XBRL INSTANCE DOCUMENT dyai20220216_8k_htm.xml XML 2575
Mailing Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477
Business Address 140 INTRACOASTAL POINTE DRIVE SUITE 404 JUPITER FL 33477 561-743-8333
DYADIC INTERNATIONAL INC (Filer) CIK: 0001213809 (see all company filings)

EIN.: 450486747 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32513 | Film No.: 22912407
SIC: 2836 Biological Products, (No Diagnostic Substances)